Redbook

David Mamet didn’t write the dialogue in this $40 million court order. It just sounds that way.

Retrieved on: 
Friday, May 12, 2023

David Mamet didn’t write the dialogue in this $40 million court order. It just sounds that way. Not much compares to the crackling dialogue of a David Mamet play.

Key Points: 

David Mamet didn’t write the dialogue in this $40 million court order. It just sounds that way.

    • Not much compares to the crackling dialogue of a David Mamet play.
    • In addition to $15 million in redress, the court order banned unsubstantiated claims and required a health warning on products containing yohimbine, an evergreen derivative sold as an impotence treatment.
    • That should have given any prudent marketer 15 million reasons to rethink their business practices, but that’s not what happened here.
    • So the FTC returned to court, arguing that Hi-Tech Pharmaceuticals, Jared Wheat, and Steven Smith were in contempt of the injunction.
    • (Merits of the case aside, we’re partial to the Maynard G. Krebs-like use of the word “cat” in this context.)
    • Although Wheat claimed to have made a good faith effort, the Court found the argument unavailing.
    • In addition, the Court cited a number of questionable transactions totaling in the multi-millions.

Bucknell University and Lycoming College collaborate to present bestselling author talks

Retrieved on: 
Wednesday, February 15, 2023

Bucknell will host Leary on Tuesday, March 7, at 7 p.m., in Bucknell Hall.

Key Points: 
  • Bucknell will host Leary on Tuesday, March 7, at 7 p.m., in Bucknell Hall.
  • Lycoming will host her on Wednesday, March 8, at 7 p.m., in the Trogner Presentation Room in the Krapf Gateway Center.
  • New York Times bestselling author Ann Leary will lecture at both Bucknell University and Lycoming College in March.
  • Leary is the New York Times bestselling author of a memoir and four novels including The Good House.

AlmaLinux Foundation Builds AlmaLinux OS 8 for s390x

Retrieved on: 
Wednesday, September 21, 2022

The AlmaLinux OS Foundation , the nonprofit that stewards the community-owned and governed open source CentOS successor AlmaLinux, is announcing that AlmaLinux 8 now supports s390x.

Key Points: 
  • The AlmaLinux OS Foundation , the nonprofit that stewards the community-owned and governed open source CentOS successor AlmaLinux, is announcing that AlmaLinux 8 now supports s390x.
  • The efforts undertaken by the AlmaLinux OS Foundation were made possible when Sine Nomine Associates (SNA) joined as a foundation member.
  • The AlmaLinux OS Foundation members supporting the rapid development of AlmaLinux include AMD, Arm, CloudLinux, and Codenotary.
  • The AlmaLinux OS falls under the purview of The AlmaLinux OS Foundation, which is a 501(c)(6) non-profit created for the benefit of the AlmaLinux OS community.

Scala Data Centers Announces CTO To Leverage Innovation And Automation Of Its Operations

Retrieved on: 
Friday, November 5, 2021

"With Villela joining our executive team, we are taking an important step to have the innovation permeating the entire company in a deep and transversal way.

Key Points: 
  • "With Villela joining our executive team, we are taking an important step to have the innovation permeating the entire company in a deep and transversal way.
  • As the CTO, Villela will lead Scala's automation and innovation initiatives, working on 4 main pillars: risk mitigation, quality improvement, delivery time reduction and greater efficiency.
  • Scala Data Centers is the Sustainable Hyperscalable Data Centers platform based in Brazil and founded by DigitalBridge.
  • We customize cutting edge solutions for each customer in the construction of state-of-the-art data centers, with high availability, high energy efficiency and very high density.

Regenative Labs Introduces AmnioText™ Dual-Layer Patch

Retrieved on: 
Thursday, September 16, 2021

PENSACOLA, Fla., Sept. 16, 2021 /PRNewswire-PRWeb/ -- Regenative Labs, the established leader in the connective tissue allograft space, today launched AmnioText Dual-Layer Patch for wounds.

Key Points: 
  • PENSACOLA, Fla., Sept. 16, 2021 /PRNewswire-PRWeb/ -- Regenative Labs, the established leader in the connective tissue allograft space, today launched AmnioText Dual-Layer Patch for wounds.
  • The Regenative Labs current suite of products are regulated by the FDA under 21 CFR part 1271 section 361, are minimally manipulated and for homologous use only.
  • "As we continue our pioneering innovation at Regenative Labs, we're proud to open yet another new market to serve patients with the introduction of AmnioText, a wound covering technology," said Tyler C. Barrett, CEO of Regenative Labs.
  • Regenative Labs has a laser-focused, expert product research and development team which follows FDA guidelines for minimal manipulation and homologous use.